Rtw Biotech Share News (RTW)

Rtw Biotech Information

Buy RTW Shares
Add RTW to Watchlist
Add RTW to Alert

Share Price Information for Rtw Biotech (RTW)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1.30

Bid: 1.30

Ask: 1.33

Change: -0.005 (-0.38%)

Spread: 0.03 (2.308%)

Open: 1.30

High: 1.30

Low: 1.29

Prev. Close: 1.32

Last checked at -

RTW Venture is an Investment Trust

To achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies.

Find out More

5 Apr 2024 12:14

RTW Biotech invests in cell and gene therapy company Obsidian

(Alliance News) - RTW Biotech Opportunities Ltd on Friday said it has backed cell and gene therapy-focused biotech Obsidian Therapeutics Inc.

2 Apr 2024 11:15

EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

20 Feb 2024 20:13

TRADING UPDATES: Franchise Brands sets targets, Cindrigo agrees loan

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

14 Feb 2024 19:53

IN BRIEF: RTW Biotech Opportunities NAV increases 2.5% in January

RTW Biotech Opportunities Ltd - London-based venture capital firm focused on biotechnology companies - Says net asset value per share at January 31 was USD1.94, up 2.5% from USD1.90 the previous month. Notes that this NAV does not reflect the completion of the Arix Bioscience PLC transaction. RTW intends to publish, at the soonest opportunity, an indicative and estimated pro forma NAV and NAV per share reflecting the completion of the transaction and new share issuance. In January, RTW said it completed its previously announced acquisition of a 25.5% stake in Arix Bioscience PLC for USD57.1 million, equivalent to GBP1.37 per Arix share. Purchase is to support its planned all-share acquisition of Arix's assets.

12 Feb 2024 19:44

TRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

12 Feb 2024 12:53

IN BRIEF: Arix Bioscience shares suspended ahead of RTW takeover

Arix Bioscience PLC - London-based venture capital firm focused on biotechnology companies - Shares suspended from the London Stock Exchange amid the company's acquisition by RTW Biotech Opportunities Ltd, a New York-based investment firm focused on the life sciences sector.

9 Feb 2024 18:53

TRADING UPDATES: Apax opts against lifting offer; DCI enters loan deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

22 Jan 2024 16:22

IN BRIEF: RTW Biotech completes Arix investment in takeover run-up

RTW Biotech Opportunities Ltd - New York-based investment firm focused on the life sciences sector - Says it completed on Friday its previously announced acquisition of a 25.5% stake in Arix Bioscience PLC for USD57.1 million, equivalent to GBP1.37 per Arix share. Purchase is to support its planned all-share acquisition of Arix's assets. Arix says RTW on January 15 received confirmation from the UK Financial Conduct Authority that it has approved the proposed change of control. Companies say that as planned, Non-Executive Directors Maureen O'Connell and Isaac Kohlberg have resigned from Arix's board, effective Friday.

11 Jan 2024 14:29

CORRECT: RTW Biotech's manager invests USD127 million in Ji Xing

(Clarifying that RTW Investments LP has made the USD127 million investment.)

8 Jan 2024 12:27

RTW Biotech Opportunities invests USD127 million in investee Ji Xing

(Alliance News) - RTW Biotech Opportunities Ltd on Monday said its manager RTW Investments LP has agreed to invest USD127 million in Ji Xing Pharmaceuticals Ltd.

14 Nov 2023 17:43

TRADING UPDATES: Microsaic in funding talks; Jarvis says no payout

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and Monday not separately reported by Alliance News:

1 Nov 2023 12:19

RTW Biotech agrees "immediately accretive" Arix Bioscience takeover

(Alliance News) - RTW Biotech Opportunities Ltd on Wednesday said it has agreed to acquire all the assets of fellow London listing Arix Bioscience PLC in exchange for new RTW shares, and to buy a 25.5% stake from Arix's largest shareholder in cash.

13 Oct 2023 18:19

TRADING UPDATES: Brandshield shareholders approve AIM delisting

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

14 Sep 2023 21:07

IN BRIEF: RTW Biotech's Rocket Pharmaceuticals makes Danon progress

RTW Biotech Opportunities Ltd - New York-based investment firm focused on the life sciences sector - Notes announcement by its largest portfolio company position, Rocket Pharmaceuticals, Inc. Says Rocket has reached alignment with the US Food and Drug Administration on the trial design for its phase two trial of RP-A501 for Danon disease, a fatal inherited cardiomyopathy for which there is currently no cure.

13 Sep 2023 14:41

EARNINGS: Frontier Developments turns to loss; Poolbeg optimistic

(Alliance News) - The following is a round-up of earnings of London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Latest Share Chat

Rtw Biotech Share News (RTW)

Share Price Information for Rtw Biotech (RTW)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Login to your account

Quickpicks are a member only feature

Login to your account